CBAY Live-Signale | Maximieren Sie Profite mit Getagraph.com

KAUFEN 57755 min ago

@ $32.47

Ausgestellt: 20 Mär 2024 @ 19:01

Rendite: 0.03%

Vorheriges Signal: Mär 19 - 19:47

Vorheriges Signal: Verkaufen

Rendite: -0.03 %

Live Chart Being Loaded With Signals

Commentary (21 Mär 2024 @ 21:00):

CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases...

Stats
Tagesvolumen	0.00
Durchschnittsvolumen	4.16M
Marktkapitalisierung	3.73B
EPS	$0 ( 2024-03-21 )
Nächstes Ertragsdatum	( $-0.320 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-32.81
ATR14	$0.00700 (0.02%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-22	Loewy Caroline M	Sell	30 000	Employee Stock Option (right to buy)
2024-03-22	Loewy Caroline M	Sell	15 000	Employee Stock Option (right to buy)
2024-03-22	Loewy Caroline M	Sell	7 500	Employee Stock Option (right to buy)
2024-03-22	Loewy Caroline M	Sell	16 000	Employee Stock Option (right to buy)
2024-03-22	Loewy Caroline M	Sell	27 705	Employee Stock Option (right to buy)

INSIDER POWER
-97.48
Last 100 transactions
Buy: 127 470 \| Sell: 9 848 383

Volumen Korrelation

Lang: -0.17 (neutral)

Kurz: -0.63 (weak negative)

Signal:(46.979) Neutral

Cymabay Therapeutics Inc Korrelation

10 Am meisten positiv korreliert
XPDB	0.96
ROCL	0.956
HWEL	0.955
IXAQ	0.953
GDNR	0.953
ARTEU	0.952
VMGA	0.952
FNVT	0.952
AVAC	0.951
PWUP	0.951

10 Am meisten negativ korreliert
RMRM	-0.983
ASPS	-0.952
BFC	-0.945
EVLO	-0.943
CLFD	-0.942
CREG	-0.941
YJ	-0.941
STAB	-0.941
SYBT	-0.939
MMAT	-0.936

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Cymabay Therapeutics Inc Korrelation - Währung/Rohstoff

0.00
( neutral )

0.12
( neutral )

Cymabay Therapeutics Inc Finanzdaten

Annual	2023
Umsatz:	$31.07M
Bruttogewinn:	$30.39M (97.81 %)
EPS:	$-0.990

FY	2023
Umsatz:	$31.07M
Bruttogewinn:	$30.39M (97.81 %)
EPS:	$-0.990

FY	2022
Umsatz:	$0
Bruttogewinn:	$-710 000 (0.00 %)
EPS:	$-1.350

FY	2021
Umsatz:	$0.00
Bruttogewinn:	$0.00 (0.00 %)
EPS:	$-1.304

Financial Reports:

No articles found.

Cymabay Therapeutics Inc

CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of primary biliary cholangitis (PBC), as well as has completed Phase 2b clinical study to treat patients with nonalcoholic steatohepatitis. The company also develops MBX-2982, which is in Phase 2a clinical study for the disease/condition of hypoglycemia in type 1 diabetics. It has a license agreement with ABW Cyclops SPV LP to support development of seladelpar for the treatment of PBC; and holds a worldwide license from Janssen Pharmaceuticals, Inc. to research, develop, and commercialize compounds with activity against an undisclosed metabolic disease target. The company was formerly known as Metabolex, Inc. CymaBay Therapeutics, Inc. was incorporated in 1988 and is headquartered in Newark, California.